FDA 执法报告 D-0107-2027 将 Direct Rx 利多卡因软膏 5.0% 含量不足召回列为 II 类
FDA drug enforcement D-0107-2027: Direct Rx — Subpotent Drug
FDA 药品召回执法报告 D-0107-2027 将 Direct Rx 的利多卡因软膏 USP 5.0%(50g 罐装,NDC 72189-0211-50)因含量不足列为 II 类召回。
FDA drug recall enforcement report — D-0107-2027
Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.
Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.
The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.
Complete official product record (including openFDA harmonized identifiers):
{
"address_1": "94 Worldwide Dr",
"address_2": "",
"center_classification_date": "20261029",
"city": "Dawsonville",
"classification": "Class II",
"code_info": "LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.",
"country": "United States",
"distribution_pattern": "Nationwide within the United States",
"event_id": "100229",
"initial_firm_notification": "Letter",
"more_code_info": "",
"openfda": {},
"postal_code": "30534-6828",
"product_description": "Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50",
"product_quantity": "493 jars",
"product_type": "Drugs",
"reason_for_recall": "Subpotent Drug",
"recall_initiation_date": "20260929",
"recall_number": "D-0107-2027",
"recalling_firm": "Direct Rx",
"report_date": "20261104",
"state": "GA",
"status": "Ongoing",
"voluntary_mandated": "Voluntary: Firm initiated"
}
来源:openFDA 已分级药品召回执法报告 · api.fda.gov